
A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application

A presbyopia-correcting eyedrop recently received FDA acceptance of its investigational new drug (IND) application


Potential presbyopia treatment coming




These options increase the depth of field to address the symptoms of presbyopia

New drug from Gensight Biologics hits pipeline

New technology and management options are going to continue to hit the market. How ODs approach each one of them will determine whether ODs benefit or not.